Biblio Discovery — Demo Discovery Service

4 results for "Chebouti, Issam"

Showing 1–4 · 0.21 seconds · RSS

  1. Journal Article Full text

    RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA

    Giannopoulou, Lydia; Chebouti, Issam; Pavlakis, Kitty et al.

    Oncotarget · 2017 · English · PubMed Central

    The RASSF1A promoter is frequently methylated in high-grade serous ovarian cancer (HGSC). We examined RASSF1A promoter methylation in primary tumors, adjacent morphologically tumor cell-free tissues and corresponding circulating tumor DNA (ctDNA) samples of patients with HGSC, using a real-time…

  2. Journal Article Full text

    Analysis of disseminated tumor cells before and after platinum based chemotherapy in primary ovarian cancer. Do stem cell like cells predict prognosis?

    Chebouti, Issam; Blassl, Christina; Wimberger, Pauline et al.

    Oncotarget · 2016 · English · PubMed Central

    BACKGROUND: We recently reported that the presence of disseminated tumor cells (DTCs) in the bone marrow (BM) of primary ovarian cancer patients (POC pts) correlated with reduced progression free survival (PFS) and overall survival (OS). Here we analyzed whether the negative prognostic influence…

  3. Journal Article Full text

    EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy

    Chebouti, Issam; Kasimir-Bauer, Sabine; Buderath, Paul et al.

    Oncotarget · 2017 · English · PubMed Central

    BACKGROUND: Assuming that tumor cell dissemination requires a shift to a mesenchymal phenotype, we analyzed the incidence of epithelial-to-mesenchymal-transition (EMT)-like circulating tumor cells (CTCs) in ovarian cancer patients and inquired, how their molecular phenotypes respond to…

  4. Journal Article Full text

    ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic outcome of ovarian cancer

    Chebouti, Issam; Kuhlmann, Jan Dominik; Buderath, Paul et al.

    Oncotarget · 2016 · English · PubMed Central

    BACKGROUND: We recently showed that the presence of ERCC1(+)CTCs is an independent predictive biomarker for platinum-resistance and poor prognosis of ovarian cancer. The goal of our current research was to determine how the auxiliary assessment of ERCC1-transcripts influences overall CTC-detection…